CD44 Promotes Multi-Drug Resistance by Protecting P-Glycoprotein From FBXO21-mediated Ubiquitination

Oncotarget - United States
doi 10.18632/oncotarget.4763
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Selective Modulation of P-Glycoprotein-Mediated Drug Resistance

British Journal of Cancer
Cancer ResearchOncology
2001English

Overcoming P-Glycoprotein Mediated Drug Resistance With Noscapine Derivatives

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2018English

Crown Ethers Reverse P-Glycoprotein-Mediated Multidrug Resistance in Cancer Cells

Scientific Reports
Multidisciplinary
2018English

Reconstitution of Drug Transport by Purified P-Glycoprotein

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Chemosensitizing Multiple Drug Resistance of Human Carcinoma by Bicyclol Involves Attenuated P-Glycoprotein, GST-P and BCL-2

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2006English

Carboxymethylcellulose-Based and Docetaxel-Loaded Nanoparticles Circumvent P-Glycoprotein-Mediated Multidrug Resistance

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2014English

Efficient Inhibition of P-Glycoprotein-Mediated Multidrug Resistance With a Monoclonal Antibody.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

DHX15 Promotes Prostate Cancer Progression by Stimulating Siah2-Mediated Ubiquitination of Androgen Receptor

Oncogene
Cancer ResearchGeneticsMolecular Biology
2017English

Erratum For: Targeting CD44 by CRISPR-Cas9 in Multi-Drug Resistant Osteosarcoma Cells

Cellular Physiology and Biochemistry
Physiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy